[A case of rectal cancer with lung metastases responding to cetuximab].
We report a 73-year-old male patient who underwent low anterior resection for rectal cancer (Stage IIIb). Nine months after the surgery, multiple metastases of liver, lung, brain and lymph node were detected. He was treated with FOLFOX4 and FOLFIRI though lung metastases progressed and caused dyspnea. Cetuximab plus irinotecan therapy was dramatically effective, which improved his quality of life for over 10 months.
Kawai
Hiromi
H
Department of Surgical Oncology, Tokyo Medical and Dental University.
Uetake
Hiroyuki
H
Kobayashi
Hirotoshi
H
Enomoto
Masayuki
M
Higuchi
Tetsuro
T
Yasuno
Masamichi
M
Iida
Satoru
S
Ishikawa
Toshiaki
T
Sugihara
Kenichi
K
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000068818:Cetuximab; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D011788:Quality of Life; D012004:Rectal Neoplasms / Q000473:pathology* / Q000601:surgery
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D000068818:Cetuximab; D002166:Camptothecin